Amlexanox Leitfaden & Dosierungstabelle
A small molecule studied for obesity-related inflammation.
| Ziel | Dosis | Häufigkeit | Dauer | Evidenz | Quelle |
|---|---|---|---|---|---|
| Renal fibrosis / CKD (preclinical, renoprotection via TBK1 inhibition) | 3–30 mg | per trial | per trial | Preclinical | PMID 41110750 |
| Painful diabetic neuropathy (preclinical, TBK1 inhibition) | 3–30 mg | per trial | per trial | Preclinical | PMID 39030571 |
A common approach: reconstitute an example 75 mg vial of Amlexanox with bacteriostatic water. The table shows the resulting concentration and the volume to draw for a 3–30 mg dose at three common water volumes.
| BAC water | Concentration | Volume / dose | Units (U-100) |
|---|---|---|---|
| 1 mL | 75 mg/mL | 0.04–0.4 mL | 4–40 |
| 2 mL | 37.5 mg/mL | 0.08–0.8 mL | 8–80 |
| 3 mL | 25 mg/mL | 0.12–1.2 mL | 12–120 |
Units shown are for a U-100 (1 mL = 100-unit) insulin syringe. Always verify your own math before drawing.
Reconstitution worked out for each common vial size:
A typical reconstitution-and-injection kit includes:
- Lyophilized peptide vial(s) — enough for the full protocol length
- Bacteriostatic water for reconstitution
- U-100 insulin syringes (one per injection)
- Alcohol prep swabs
- A sharps container for safe disposal
Storage & handling
Lyophilized (freeze-dried) peptide is typically kept refrigerated and protected from light; once reconstituted with bacteriostatic water it is generally refrigerated at 2–8 °C and used within a few weeks. Follow aseptic technique to avoid contamination, per CDC injection-safety guidance.
Injection technique
Subcutaneous injections are usually given into the fat of the abdomen or thigh: clean the site with an alcohol swab, pinch the skin, insert at the recommended angle, and rotate sites to protect the tissue. See MedlinePlus for a step-by-step subcutaneous-injection guide.
General aseptic-technique and injection references for educational use — they are not specific to any research compound.
EN
BR
ES
FR
DE
RU